Gene therapy: ‘Now I can see my own face again’
Jake Ternent was the first UK NHS patient to undergo revolutionary gene therapy to improve his sight. …
In 2019 the NHS agreed to fund the treatment, Luxturna, the first in a new generation of gene therapies for conditions causing blindness. It costs about £600,000 per patient to treat both eyes, though the NHS has agreed a confidential discount with the makers Novartis.
About The Author
